73 related articles for article (PubMed ID: 6674584)
1. [In vitro augmentation of human natural killer cell activity by pokeweed mitogen-stimulated lymphocytes].
Matsumoto Y; Katoh Y
Rinsho Byori; 1983 Oct; 31(10):1122-6. PubMed ID: 6674584
[No Abstract] [Full Text] [Related]
2. Suppression of natural killer activity and antibody-dependent cellular cytotoxicity by cultured human lymphocytes.
Nair MP; Schwartz SA
J Immunol; 1981 Jun; 126(6):2221-9. PubMed ID: 6453160
[No Abstract] [Full Text] [Related]
3. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
Oshimi K; Gonda N; Sumiya M; Kano S
Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
5. Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus.
Beale MG; Nash GS; Bertovich MJ; MacDermott RP
J Immunol; 1982 Jan; 128(1):486-91. PubMed ID: 6976380
[No Abstract] [Full Text] [Related]
6. Immunoregulatory aberrations in systemic lupus erythematosus.
Fauci AS; Steinberg AD; Haynes BF; Whalen G
J Immunol; 1978 Oct; 121(4):1473-9. PubMed ID: 359708
[No Abstract] [Full Text] [Related]
7. [Natural cytotoxicity in systemic lupus erythematosus patients].
Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
[No Abstract] [Full Text] [Related]
8. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
Ewan PW; Barrett HM; Pusey CD
J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
[TBL] [Abstract][Full Text] [Related]
9. Enhancement by TP-1, a thymic extract, of pokeweed mitogen-induced differentiation of B cells from normal subjects but not of those from patients with systemic lupus erythematosus.
Fiorilli M; Sirianni MC; Pandolfi F; Pucillo LP; Letta T; Aiuti F
Thymus; 1982 Jan; 4(1):1-7. PubMed ID: 6977207
[TBL] [Abstract][Full Text] [Related]
10. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of specific anti-influenza antibody production by cultured lymphocytes from patients with systemic lupus erythematosus following influenza immunization.
Mitchell DM; Fitzharris P; Knight RA; Schild GC; Snaith ML
Clin Exp Immunol; 1982 Aug; 49(2):290-6. PubMed ID: 7127906
[TBL] [Abstract][Full Text] [Related]
12. Natural killer augmentation in systemic lupus erythematosus via a soluble mediator derived from human lymphocytes.
Kaufman DB
Arthritis Rheum; 1982 May; 25(5):562-7. PubMed ID: 7082401
[TBL] [Abstract][Full Text] [Related]
13. Adherent cell requirement for PWM-stimulated factor suppression of natural killer cytotoxicity.
Hofman F; Rand N; Fahey JL
Cell Immunol; 1981 Mar; 58(2):356-65. PubMed ID: 6452221
[No Abstract] [Full Text] [Related]
14. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell activity in untreated systemic lupus erythematosus.
Oshimi K; Sumiya M; Gonda N; Kano S; Takaku F
Ann Rheum Dis; 1982 Aug; 41(4):417-20. PubMed ID: 7114924
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cytotoxicity of human lymphocytes in vitro. II. Cytotoxicity enhanced by BCG, PHA, PWM, PPD and LPS-Su against a human skin cancer cell line.
Kondo S; Sato K; Aso K
J Dermatol; 1983 Oct; 10(5):469-74. PubMed ID: 6366020
[No Abstract] [Full Text] [Related]
17. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
[TBL] [Abstract][Full Text] [Related]
18. In vitro modulation of interleukin-2-mediated human peripheral mononuclear cell proliferation and antitumor cytotoxicity by 5-fluorouracil.
Brazowski E; Eytan K; Eisenthal A
Anticancer Res; 2007; 27(6B):4135-41. PubMed ID: 18225584
[TBL] [Abstract][Full Text] [Related]
19. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
Kozlowski SH; Hirsen DJ; Jackson EJ
J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of natural killer cell activity].
Abo T
Nihon Rinsho; 1990 Feb; 48 Suppl():726-9. PubMed ID: 2355603
[No Abstract] [Full Text] [Related]
[Next] [New Search]
